NYSE:PG

Procter & Gamble (PG)

149.31
-2.10 (1.39%)
as of Jul 6, 2026, 8:00:00 pm Market Open.
240 watching
0
Investor Insights
star iconJul 6, 2026, 12:00 am

This summary was created by AI, based on 11 opinions in the last 12 months.

Procter & Gamble (PG) is currently facing a challenging economic landscape, with experts indicating that consumer products are experiencing difficulties. The company has been described as a defensive stock due to its strong brand portfolio and consistent dividend payments near 3%. Despite a decline in stock performance, with a noted drop of 14.4% over the past year, some analysts believe it is an opportune time to invest, albeit gradually, given its quality and dividend aristocrat status. However, there are concerns about low earnings growth, rising input costs, and a persistently cautious consumer sentiment. While PG maintains strong margins, its revenue growth has been slow, prompting mixed sentiments regarding its immediate future, especially as it approaches an earnings report amidst a weak economy.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Fair Value
review icon
Similar
Nestle, NSRGY
PAST TOP PICK
(Top Pick May 5/11, Up 0.15%) sold it about 3 weeks later.
COMMENT
This is the sort of stock that is poised to do well in this kind of market. He doesn't care for it, because it is so big it is growth challenged. A good alternative might be Unilever (UL-N).
WEAK BUY
An orphans and widows stock and you can't really go wrong. It is a Buy but you are not going to make a lot of money on it. Making a lot of movement into the emerging markets.
TOP PICK
This is a time period when you want to favour defensive stocks. Brand power is extremely strong. Stock is very close to the top of where it was a few months ago but it is the beginning of its seasonality so he is not too concerned. If it comes back down, he’ll reassess.
COMMENT
Proctor & Gamble (PG-N) and Colgate Palmolive (CL-N) are both high quality consumer staple names. This one decided not to increase prices as quickly as others so their volume has suffered. A great long-term hold. Product innovation is quite good. If the market turns a bit more defensive, this could be a safe one to get into. About 35% emerging market exposure.
HOLD
Defensive play in an environment where it is not being rewarded. Trades at a fairly high multiple. Not performing well but still fairly rich. OK for a portfolio but don’t overweight.
BUY
Good international exposure and ability to participate in the emerging market growth.
COMMENT
Stable earnings grower. At this point in the cycle you want to be in more cyclical names than consumer staples. This one has safety and gradual growth. Has under performed the S&P 500 in the last 6-12 months.
DON'T BUY
Great company, very well managed. Today and for along while has represented a defensive play. Struggles to grow revenue and earnings. It’s an expensive stock and doesn’t warrant owning the company. It’s going to have its place in a particular cycle.
BUY
In this economy and market, this is a defensive company. You can’t go wrong here.
DON'T BUY
Money flow had gone to these areas because it was a place to hide. He is staying away from defensive areas. Too expensive at 16X earnings. Struggling for revenue and earnings growth.
COMMENT
Good company and defensive play but not enough growth for him.
BUY
Great company but when the economy turned down, people traded down to lower end and house brands. If you are a long-term investor, this is a fabulous company with a great franchise and international reputation. Growing in developing markets.
BUY
Consumer staples has not done well. Did better going through 2008 and into 2009 because they are defensive but haven't benefited from the rebound. At this point they're much more interesting. 60% of their business comes from outside of the US. Restructuring and on the cost side are making some good gains. 2.9% dividend.
WEAK BUY
Makes sense in this kind of environment. Is a long-term hold. Not a lot of upside potential. Well run company. Would prefer other consumer staples.
Showing 151 to 165 of 234 entries